Zobrazeno 1 - 1
of 1
pro vyhledávání: '"da Silva Liberio M"'
Autor:
Dietrich S; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany., Oleś M; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Lu J; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Sellner L; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Anders S; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Velten B; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Wu B; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Hüllein J; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., da Silva Liberio M; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Walther T; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Wagner L; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Rabe S; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Ghidelli-Disse S; Cellzome, Heidelberg, Germany., Bantscheff M; Cellzome, Heidelberg, Germany., Oleś AK; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Słabicki M; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Mock A; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Oakes CC; Division of Hematology, Departments of Internal Medicine and Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA.; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Centre, Heidelberg, Germany., Wang S; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Oppermann S; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Lukas M; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Kim V; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Sill M; Division of Biostatistics, German Cancer Research Centre, Heidelberg, Germany., Benner A; Division of Biostatistics, German Cancer Research Centre, Heidelberg, Germany., Jauch A; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany., Sutton LA; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Young E; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Liu X; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Jethwa A; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Lee KS; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany., Lewis J; European Molecular Biology Laboratory (EMBL), Chemical Biology Core Facility, Heidelberg, Germany., Putzker K; European Molecular Biology Laboratory (EMBL), Chemical Biology Core Facility, Heidelberg, Germany., Lutz C; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Rossi D; Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Mokhir A; Friedrich-Alexander-University of Erlangen-Nürnberg, Department of Chemistry and Pharmacy, Organic Chemistry II, Erlangen, Germany., Oellerich T; Hematology/Oncology, Department of Medicine, Johann Wolfgang Goethe University, Frankfurt, Germany; Department of Haematology, Cambridge Institute of Medical Research, University of Cambridge, Cambridge, United Kingdom.; German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany., Zirlik K; German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Hematology/Oncology, University Hospital Freiburg, Freiburg, Germany and Tumorzentrum ZeTuP Chur, Chur, Schweiz., Herling M; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany., Nguyen-Khac F; INSERM U1138, Université Pierre et Marie Curie-Paris and Service d'Hématologie Biologique, Hôpital Pitié-Salpêtrière, Paris, France., Plass C; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Centre, Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany., Andersson E; Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland and Department of Hematology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland., Mustjoki S; Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland and Department of Hematology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland., von Kalle C; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Heidelberg Centre for Personalized Oncology, DKFZ-HIPO, DKFZ, Heidelberg, Germany., Ho AD; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Hensel M; Mannheim Oncology Practice, Mannheim, Germany., Dürig J; German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Hematology, University Hospital Essen, Essen, Germany., Ringshausen I; Department of Hematology, University of Cambridge, Cambridge, United Kingdom., Zapatka M; Division of Molecular Genetics, German Cancer Research Centre, Heidelberg, Germany., Huber W; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany., Zenz T; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany.; Molecular Therapy in Hematology and Oncology, and Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Centre, Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Hematology, University of Zürich, Zürich, Switzerland.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2018 Jan 02; Vol. 128 (1), pp. 427-445. Date of Electronic Publication: 2017 Dec 11.